U.S. Food and Drug Administration "enforcement in the social media space has historically been somewhat limited, but recent activity suggests that the FDA is taking a closer look at how pharmaceutical ...
Regulators claim Pfizer’s ads created a misleading impression by describing Adcetris as a treatment for broader T-cell lymphoma populations than those covered by its FDA-approved label. The FDA also ...